There is, however, no pharmacological treatment currently approved to treat hydrocephalus. Additionally, nearly 20 percent of patients with normal pressure hydrocephalus also have type 2 diabetes and take sodium/glucose cotransporter 2 (SGLT2) inhibitors to manage their blood sugar.
Patients with type 2 diabetes treated with automated insulin delivery significantly reduced glucose levels compared to those receiving usual care, highlighting the AID system's effectiveness.
"Type 2 diabetes is at epidemic proportions in both India and Pakistan and increasing rapidly in Bangladesh as well. The latest estimates show that over 33% of the global burden of type 2 diabetes is from South Asian populations, both migrant and non-migrant." - Moneeza Siddiqui, Epidemiologist at Queen Mary University of London.